Zuoshun HE

Zuoshun HE


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2023 in Environment International
Verified
Journal Article
Open access
ZMZongqin Mei
Zongqin Mei
GLGuofen Liu
Guofen Liu
BZBo Zhao
Bo Zhao
ZHZuoshun HE
Zuoshun HE
GSGU shiyan
GU shiyan
Lead is a common environmental heavy metal contaminant. Humans are highly susceptible to lead accumulation in the body, which causes nervous system damage and leads to a variety of nervous system diseases, such as Alzheimer's disease, Parkinson's disease, and autism spectrum disorder. Recent research has focused on the mechanisms of lead-induced neurotoxicity at multiple levels, including DNA methylation, histone modifications, and non-coding RNAs, which are involved in various lead-induced nervous system diseases. We reviewed the latest articles and summarised the emerging roles of DNA methylation, histone modification, and non-coding RNAs in lead-induced neurotoxicity. Our summary provides a theoretical basis and directions for future research on the prevention, diagnosis, and treatment of lead-induced neurological diseases.

1 June 2021 in Toxicology Letters
Verified
Journal Article
Closed access
TQTengjiao Qu
Tengjiao Qu
YMYahao Mou
Yahao Mou
JDJiao Dai
Jiao Dai
XZXiaoli Zhang
Xiaoli Zhang
MLMengzhu Li
Mengzhu Li
ZHZuoshun HE
Zuoshun HE

Verified
Journal Article
Open access
PDF file
ZMZongqin Mei
Zongqin Mei
YMYahao Mou
Yahao Mou
NZNan Zhang
Nan Zhang
XLXiaoyu Liu
Xiaoyu Liu
ZHZuoshun HE
Zuoshun HE
GSGU shiyan
GU shiyan
N6-metyladenosine (m6A), one of the most common RNA methylation modifications in mammals, has attracted extensive attentions owing to its regulatory roles in a variety of physiological and pathological processes. As a reversible epigenetic modification on RNAs, m6A is dynamically mediated by the functional interplay among the regulatory proteins of methyltransferases, demethylases and methyl-binding proteins. In recent years, it has become increasingly clear that m6A modification is associated with the production and function of microRNAs (miRNAs). In this review, we summarize the specific kinds of m6A modification methyltransferases, demethylases and methyl-binding proteins. In particular, we focus on describing the roles of m6A modification and its regulatory proteins in the production and function of miRNAs in a variety of pathological and physiological processes. More importantly, we further discuss the mediating mechanisms of miRNAs in m6A modification and its regulatory proteins during the occurrence and development of various diseases.

6 July 2022 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
YSYifei Sun
Yifei Sun
GLGuofen Liu
Guofen Liu
MLMengzhu Li
Mengzhu Li
LWLei Wang
Lei Wang
ZHZuoshun HE
Zuoshun HE
GSGU shiyan
GU shiyan

17 August 2019 in Biological Trace Element Research
Verified
Journal Article
Closed access
GSGU shiyan
GU shiyan
JDJiao Dai
Jiao Dai
TQTengjiao Qu
Tengjiao Qu
ZHZuoshun HE
Zuoshun HE

26 June 2023 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
NZNan Zhang
Nan Zhang
YSYifei Sun
Yifei Sun
ZMZongqin Mei
Zongqin Mei
ZHZuoshun HE
Zuoshun HE
GSGU shiyan
GU shiyan
N6-methyladenosine (m6A), one of the most common RNA methylation modifications, has emerged in recent years as a new layer of the regulatory mechanism controlling gene expression in eukaryotes. As a reversible epigenetic modification, m6A not only occurs on mRNAs but also on Long non-coding RNAs (LncRNAs). As we all known, despite LncRNAs cannot encode proteins, they affect the expression of proteins by interacting with mRNAs or miRNAs, thus playing important roles in the occurrence and development of a variety of tumors. Up to now, it has been widely accepted that m6A modification on LncRNAs affects the fate of the corresponding LncRNAs. Interestingly, levels and functions of m6A modifications are also mediated by LncRNAs through affecting the m6A methyltransferases (METTL3, METTL14, WTAP, METTL16, etc.), demethylases (FTO, ALKBH5) and methyl-binding proteins (YTHDFs, YTHDCs, IGF2BPs, HNRNPs, etc.), which are collectively referred to as “m6A regulators”. In this review, we summarized the mutual regulation mechanisms between N6-methyladenosine modification and LncRNAs in cancer progression, metastasis, invasion and drug resistance. In detail, we focus on the specific mechanisms of m6A modification, which is mediated by methyltransferases and demethylases, involves in the regulation of LncRNA levels and functions in the first part. And section two intensively displays the mediation roles of LncRNAs in m6A modification via changing the regulatory proteins. At last part, we described the interaction effects between LncRNAs and methyl-binding proteins of m6A modification during various tumor occurrence and development.